AAAAAA
Results: 1-25/45
Authors:
Alander, SW
Dowd, MD
Bratton, SL
Kearns, GL
Citation: Sw. Alander et al., Pediatric acetaminophen poisoning - In reply, ARCH PED AD, 155(3), 2001, pp. 418-419
Authors:
Kearns, GL
Abdel-Rahman, SM
Blumer, JL
Reed, MD
James, LP
Jacobs, RF
Welshman, IR
Jungbluth, GL
Stalker, DJ
Citation: Gl. Kearns et al., Single dose pharmacokinetics of linezolid in infants and children (vol 19,pg 1178, 2000), PEDIAT INF, 20(8), 2001, pp. 732-732
Authors:
Lowry, JA
Corry, A
Fitzmaurice, L
Jackson, MA
Kearns, GL
Citation: Ja. Lowry et al., Coadministration of mefloquine and chloroquine: Use of a pharmacokinetic-based approach to reduce toxicity, PEDIAT INF, 20(2), 2001, pp. 223-224
Authors:
James, LP
Farrar, HC
Sullivan, JE
Givens, TG
Kearns, GL
Wasserman, GS
Walson, PD
Hinson, JA
Pumford, NR
Citation: Lp. James et al., Measurement of acetaminophen-protein adducts in children and adolescents with acetaminophen overdoses, J CLIN PHAR, 41(8), 2001, pp. 846-851
Authors:
Knorr, B
Nguyen, HH
Kearns, GL
Villaran, C
Boza, ML
Reiss, TF
Rogers, JD
Zhang, J
Larson, P
Spielberg, S
Citation: B. Knorr et al., Montelukast dose selection in children ages 2 to 5 years: Comparison of population pharmacokinetics between children and adults, J CLIN PHAR, 41(6), 2001, pp. 612-619
Authors:
Reed, MD
Rodarte, A
Blumer, JL
Khoo, KC
Akbari, B
Pou, S
Kearns, GL
Citation: Md. Reed et al., The single-dose pharmacokinetics of midazolam and its primary metabolite in pediatric patients after oral and intravenous administration, J CLIN PHAR, 41(12), 2001, pp. 1359-1369
Authors:
Pearce, RE
Gotschall, RR
Kearns, GL
Leeder, JS
Citation: Re. Pearce et al., Cytochrome P450 involvement in the biotransformation of cisapride and racemic norcisapride in vitro: Differential activity of individual human CYP3A isoforms, DRUG META D, 29(12), 2001, pp. 1548-1554
Authors:
Ward, RM
Bates, BA
Benitz, WE
Burchfield, DJ
Ring, JC
Walls, RP
Walson, PD
Alexander, J
Bennett, DR
Cvetkovich, T
Hagino, OR
MacLeod, SM
Mithani, S
Mulinare, J
Riley, LE
Yaffe, SJ
Cote, CJ
Meltzer, EO
Kearns, GL
McCarver, DG
Notterman, DA
Spielberg, SJ
Koteras, RJ
Citation: Rm. Ward et al., Acetaminophen toxicity in children, PEDIATRICS, 108(4), 2001, pp. 1020-1024
Authors:
Behm, MO
Kearns, GL
Citation: Mo. Behm et Gl. Kearns, Treatment of pain with gabapentin in a neonate, PEDIATRICS, 108(2), 2001, pp. 482-485
Authors:
Wang, KS
Kearns, GL
Mock, DM
Citation: Ks. Wang et al., The clearance and metabolism of biotin administered intravenously to pigs in tracer and physiologic amounts is much more rapid than previously appreciated, J NUTR, 131(4), 2001, pp. 1271-1278
Authors:
Van Overmeire, B
Touw, D
Schepens, PJC
Kearns, GL
van den Anker, JN
Citation: B. Van Overmeire et al., Ibuprofen pharmacokinetics in preterm infants with patent ductus arteriosus, CLIN PHARM, 70(4), 2001, pp. 336-343
Authors:
James, LP
Farrar, HC
Darville, TL
Sullivan, JE
Givens, TG
Kearns, GL
Wasserman, GS
Simpson, PM
Hinson, JA
Citation: Lp. James et al., Elevation of serum interleukin 8 levels in acetaminophen overdose in children and adolescents, CLIN PHARM, 70(3), 2001, pp. 280-286
Authors:
James, LP
Wilson, JT
Simar, R
Farrar, HC
Kearns, GL
Simpson, PM
Hinson, JA
Pumford, NR
Citation: Lp. James et al., Evaluation of occult acetaminophen hepatotoxicity in hospitalized childrenreceiving acetaminophen, CLIN PEDIAT, 40(5), 2001, pp. 243-248
Authors:
Alander, SW
Dowd, MD
Bratton, SL
Kearns, GL
Citation: Sw. Alander et al., Pediatric acetaminophen overdose - Risk factors associated with hepatocellular injury, ARCH PED AD, 154(4), 2000, pp. 346-350
Authors:
Kearns, GL
Bradley, JS
Jacobs, RF
Capparelli, EV
James, LP
Johnson, KM
Abdel-Rahman, SM
Citation: Gl. Kearns et al., Single dose pharmacokinetics of pleconaril in neonates, PEDIAT INF, 19(9), 2000, pp. 833-839
Authors:
Williams, KM
Kearns, GL
Citation: Km. Williams et Gl. Kearns, Lipid amphotericin preparations, PEDIAT INF, 19(6), 2000, pp. 567-569
Authors:
Lowry, JA
Kearns, GL
Citation: Ja. Lowry et Gl. Kearns, Monitoring of aminoglycoside serum concentrations, PEDIAT INF, 19(5), 2000, pp. 489-490
Authors:
Kearns, GL
Abdel-Rahman, SM
Blumer, JL
Reed, MD
James, LP
Jacobs, RF
Welshman, IR
Jungbluth, GL
Stalker, DJ
Citation: Gl. Kearns et al., Single dose pharmacokinetics of linezolid in infants and children, PEDIAT INF, 19(12), 2000, pp. 1178-1184
Authors:
Komoroski, EM
Komoroski, RA
Valentine, JL
Pearce, JM
Kearns, GL
Citation: Em. Komoroski et al., The use of nuclear magnetic resonance spectroscopy in the detection of drug intoxication, J ANAL TOX, 24(3), 2000, pp. 180-187
Authors:
Kearns, GL
Citation: Gl. Kearns, Impact of developmental pharmacology on pediatric study design: Overcomingthe challenges, J ALLERG CL, 106(3), 2000, pp. S128-S138
Authors:
Abdel-Rahman, SM
Maxson, S
Teo, C
Hubbard, AE
Kearns, GL
Citation: Sm. Abdel-rahman et al., Cerebrospinal fluid pharmacokinetics of cefpodoxime proxetil in piglets, J CLIN PHAR, 40(3), 2000, pp. 290-295
Authors:
James, LP
Marotti, T
Stowe, CD
Farrar, HC
Taylor, BJ
Kearns, GL
Citation: Lp. James et al., Pharmacokinetics and pharmacodynamics of famotidine in infants. (vol 38, pg 1089, 1998), J CLIN PHAR, 40(11), 2000, pp. 1298-1298
Authors:
Bradley, JS
Kearns, GL
Reed, MD
Capparelli, EV
Vincent, J
Citation: Js. Bradley et al., Pharmacokinetics of a fluoronaphthyridone, trovafloxacin (CP 99,219), in infants and children following administration of a single intravenous dose of alatrofloxacin, ANTIM AG CH, 44(5), 2000, pp. 1195-1199
Authors:
Wilson, JT
Brown, RD
Kearns, GL
Citation: Jt. Wilson et al., Clinical trials with antipyretic drugs in febrile children: A position statement on exclusion criteria, CURR THER R, 61(1), 2000, pp. 31-35
Authors:
Streetman, DS
Bleakley, JF
Kim, JS
Nafziger, AN
Leeder, JS
Gaedigk, A
Gotschall, R
Kearns, GL
Bertino, JS
Citation: Ds. Streetman et al., Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail", CLIN PHARM, 68(4), 2000, pp. 375-383